Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharm Biomed Anal ; 8(1): 49-60, 1990.
Article in English | MEDLINE | ID: mdl-2102265

ABSTRACT

An automated assay for the determination of penicillin in formulations suitable for use in pharmaceutical quality control is presented. The method is based on the classical iodometric penicillin assay which is incorporated in a flow injection analysis (FIA) system. The required hydrolysis is performed on-line by using an immobilised penicillinase reactor. Packed-bed and single-bead-string enzyme reactors are compared. It turns out that a packed-bed penicillinase reactor (10 cm x 1.5 mm i.d.) provides complete hydrolysis within short residence time, while only little back-pressure is generated. This enzyme reactor is stable for at least 9 months. Enzymatic hydrolysis of the beta-lactam ring results in the formation of the corresponding penicilloic acid, which consumes iodine. The iodine consumption is determined colorimetrically by measuring the decrease of the absorbance of the blue coloured iodine/starch complex. The optimum reactor length and flow rate for the colourimetrical detection reaction are determined. The optimised method is applied to the assay of penicillin in formulations and the results are compared with the "true" results obtained with a reference method: a mercurimetric titration. The reliability of the flow injection method is evaluated quantitatively by determining the maximum total error (MTE). The reliability is shown to be highest when measuring at a 0.3-mM level. Eight formulations including capsules, tablets and injectables containing penicillin G, amoxicillin or flucloxacillin are assayed. The MTE does not exceed the 6% level and the most probable MTE is between 1.5 and 3.5%.


Subject(s)
Enzymes, Immobilized , Iodine , Penicillinase , Penicillins/analysis
2.
J Chromatogr ; 276(2): 385-94, 1983 Sep 09.
Article in English | MEDLINE | ID: mdl-6630387

ABSTRACT

A procedure for the determination of amikacin in serum is described. The aminoglycoside is extracted from serum by using a disposable cation-exchange column. The eluate of this column is derivatized with 1-fluoro-2,4-dinitrobenzene and subsequently analysed by reversed-phase high-performance liquid chromatography with ultraviolet detection at 365 nm. The absolute recovery of amikacin by this procedure is 72%. Kanamycin is used as the internal standard. The sensitivity is 1 mg/l for amikacin with samples of 200 microliters. Precision, expressed as the coefficient of variation, is about 3% in the therapeutic concentration range. The 2,4-dinitrophenyl derivative of amikacin is synthesized on a preparative scale by a new method and its structure is demonstrated to be the fully derivatized amikacin. The analysis of serum samples obtained in an in vivo experiment correlates well with the results from a microbiological assay.


Subject(s)
Amikacin/blood , Kanamycin/analogs & derivatives , Chemical Phenomena , Chemistry , Chromatography, High Pressure Liquid/methods , Humans , Kanamycin/blood , Spectrophotometry, Ultraviolet/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...